Eupraxia Pharmaceuticals Inc（EPRX）價格預測

$7.500

+0.050 (+0.67%)收盤時

價格預測

1-Day Price Prediction

+4.89%

1-Week Prediction

+6.65%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

EPRX 相似圖表分析預測

Alphio's EPRX stock price prediction model matches the current Eupraxia Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $7.87 (+4.89%). The 1-week path is $8.00 (+6.65%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 Eupraxia Pharmaceuticals Inc 股票嗎？

Eupraxia Pharmaceuticals Inc (EPRX) is a good buy right now due to its current price of $6.67, which is significantly below analyst price targets, with Oppenheimer setting a target of $17 and Stifel at $25. The recent positive Phase 1b/2a data for its lead therapy EP-104GI shows a 72% reduction in eosinophil count, indicating strong potential for future growth. However, the company reported a widening net loss of $12.7 million for Q1 2026, which is a risk to consider.

EPRX 股價於 Thursday 收在 $7.50，此前上漲 +0.67%

Eupraxia Pharmaceuticals Inc (EPRX) last closed at $7.5, gaining +0.67%. These facts feed the 1-day and 1-week EPRX price prediction above.

預測驅動因素

Eupraxia Pharmaceuticals Inc（EPRX）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Positive

Bullish

SMA 200

Positive

Bullish

相似圖表形態

近期走勢與 EPRX 最接近的股票，依相似度排序。

HMY

89.18%

-2.89%

USFD

88.02%

-8.20%

GNW

87.98%

+82.00%

86.64%

+11.69%

ANF

86.41%

-1.19%

EPRX 季節性分析

Historically the probability of a positive September return for EPRX is 47.73%. December offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…